Essential Premium

RA Capital Doubles Down on Private Deals as Year-End Frenzy Builds

The biopharma specialist hedge fund is on track for its busiest quarter yet, pouring money into startups while launching a new vehicle focused on planetary health.

Crypto Is the Secret Sauce University Endowments Don’t Want to Talk About

For the first time, crypto and digital assets are reaping returns at elite universities.

Sponsored

Fireside Chat: Why We’re Bullish About Asset-Based Private Credit

Greenlight Builds Momentum After Summer Losses

David Einhorn’s hedge fund posts a gain in November, extending a three-month rally that has lifted returns for the year.

Related Content

Hedge Funds Stand to Gain as Biopharma IPOs Heat Up

Steve Taub

Facing Losses, Ackman Exits Chipotle and Nike

Michelle Celarier

How Wary Asset Managers Learned to Stop Worrying and Embrace Crypto

Leah McGrath Goodman

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram